Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours

(2009) C. Sessa et al.   EUROPEAN JOURNAL OF CANCER

New-generation platinum agents for solid tumors

(2009) Neel Shah et al.   Future Oncology

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

(2009) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

(2008) M. von Mehren et al.   ANNALS OF ONCOLOGY

Platinum Resistance: The Role of DNA Repair Pathways

(2008) L. P. Martin et al.   CLINICAL CANCER RESEARCH

Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma

(2008) J.-Y. Blay et al.   CLINICAL CANCER RESEARCH